Semi Zouiouich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Semi Zouiouich has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Emily Vogtmann
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
29 shared publications - Christian C. Abnet
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
28 shared publications - Jianxin Shi
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
28 shared publications - Rashmi Sinha
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD
28 shared publications - Yunhu Wan
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
28 shared publications - Carolina Porras
Agencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San José, Costa Rica
17 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1005251
Associations of food processing and dietary risk factors with colorectal cancer incidence in the NIH-AARP Diet and Health Study: A cohort study
Background: Ultra-processed foods (UPF) account for >50% of energy intake by US adults. UPF intake can include dietary components linked to lower colorectal cancer (CRC) risk, such as whole grain and dairy products, and others linked to higher CRC risk, such as processed meats, potentially explaining the heterogeneity of evidence for an association between UPF and CRC risk. Our goal was to estimate the associations of UPF and established CRC-related dietary factors, by UPF and non-UPF source, with CRC incidence in a large cohort study. Methods and findings: US adults, aged 50–71, who enrolled in the NIH-AARP Diet and Health Study in 1995–96, self-reported dietary intake using a food frequency questionnaire (FFQ). Median UPF intake was 293 g/1000 kcal/day or 43% of daily energy intake. We assigned disaggregated FFQ items to Nova classification and categorized UPF intake (g/1000 kcal/day) into sex-specific quintiles. Participants who were cancer-free at baseline ( N = 461,682) were followed for cancer incidence through 2018, and 10,075 colorectal adenocarcinoma cases were diagnosed. We used multivariable-adjusted Cox proportional hazards regression models, adjusted for demographic, lifestyle, and health-related factors, including age, sex, race/ethnicity, education, physical activity, smoking, and alcohol drinking, to estimate associations for UPF and related dietary components with CRC incidence. UPF intake was not associated with CRC incidence (hazard ratio 5th versus 1st quintile 0.97; 95% confidence interval [0.91–1.03]; p trend = 0.55). Whole grain, fiber, dairy, and calcium intakes from UPF sources were inversely but meat intake from UPF sources was positively associated with CRC incidence. The main limitations of the study relate to its observational design and include potential residual confounding and exposure misclassification owing to systematic or random error in self-reported dietary data. Conclusions: Total UPF intake was not associated with incident CRC in this cohort of older, US adults. This may be explained, in part, by opposing associations of some UPF with CRC risk. Our findings support current dietary guidance to consume whole grains, fiber, dairy, and calcium and avoid processed meat for CRC prevention.
- 15 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1005251
Open AccessAssociations of food processing and dietary risk factors with colorectal cancer incidence in the NIH-AARP Diet and Health Study: A cohort study
Background: Ultra-processed foods (UPF) account for >50% of energy intake by US adults. UPF intake can include dietary components linked to lower colorectal cancer (CRC) risk, such as whole grain and dairy products, and others linked to higher CRC risk, such as processed meats, potentially explaining the heterogeneity of evidence for an association between UPF and CRC risk. Our goal was to estimate the associations of UPF and established CRC-related dietary factors, by UPF and non-UPF source, with CRC incidence in a large cohort study. Methods and findings: US adults, aged 50–71, who enrolled in the NIH-AARP Diet and Health Study in 1995–96, self-reported dietary intake using a food frequency questionnaire (FFQ). Median UPF intake was 293 g/1000 kcal/day or 43% of daily energy intake. We assigned disaggregated FFQ items to Nova classification and categorized UPF intake (g/1000 kcal/day) into sex-specific quintiles. Participants who were cancer-free at baseline ( N = 461,682) were followed for cancer incidence through 2018, and 10,075 colorectal adenocarcinoma cases were diagnosed. We used multivariable-adjusted Cox proportional hazards regression models, adjusted for demographic, lifestyle, and health-related factors, including age, sex, race/ethnicity, education, physical activity, smoking, and alcohol drinking, to estimate associations for UPF and related dietary components with CRC incidence. UPF intake was not associated with CRC incidence (hazard ratio 5th versus 1st quintile 0.97; 95% confidence interval [0.91–1.03]; p trend = 0.55). Whole grain, fiber, dairy, and calcium intakes from UPF sources were inversely but meat intake from UPF sources was positively associated with CRC incidence. The main limitations of the study relate to its observational design and include potential residual confounding and exposure misclassification owing to systematic or random error in self-reported dietary data. Conclusions: Total UPF intake was not associated with incident CRC in this cohort of older, US adults. This may be explained, in part, by opposing associations of some UPF with CRC risk. Our findings support current dietary guidance to consume whole grains, fiber, dairy, and calcium and avoid processed meat for CRC prevention.
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Investigating the role of the intestinal microbiota in colorectal cancer development : epidemiological approaches
Étude du rôle du microbiote intestinal dans la carcinogenèse colorectale : approches épidémiologiques: Le microbiome intestinal désigne l'ensemble des micro-organismes présents dans le tractus gastro-intestinal. Une symbiose dynamique entre l'hôte et le microbiome existe dans l'intestin et des interactions spécifiques entre le microbiome et le métabolisme de l'hôte, et son système immunitaire, sont essentielles pour façonner la physiologie de l'hôte. L'hypothèse que la perturbation de cette symbiose joue un rôle dans le développement de diverses maladies chroniques, y compris du cancer colorectal, a été émise. En effet, il existe de plus en plus de preuves expérimentales selon lesquelles le microbiome intestinal influence potentiellement le développement de tumeurs par le biais d'une dérégulation du métabolisme de l'hôte et de sa fonction immunitaire. Cependant, les données épidémiologiques reliant le microbiome intestinal à la carcinogenèse colorectale restent limitées car très peu de cohortes existantes ont collecté des échantillons fécaux. Les programmes de dépistage du cancer colorectal, dans lesquels des millions d'échantillons de selles sont prélevés chaque année, pourraient fournir de riches opportunités pour établir des cohortes basées sur la population avec des échantillons répétés et prospectivement collectés. La première partie de la thèse résume de manière systématique la littérature épidémiologique actuelle qui a été publiée au cours de la dernière décennie sur l'association entre le microbiome et le cancer. Nos résultats ont souligné que pour la plupart des indicateurs du microbiome, les preuves étaient encore trop faibles pour tirer des conclusions définitives concernant leur rôle dans le cancer. La deuxième partie de la thèse étudie l'association entre la résistance à l'insuline et l'inflammation - des facteurs de risque reconnus du cancer colorectal - et le microbiome intestinal, dans deux cohortes populationnelles : The Northern Finland Birth Cohort et TwinsUK. Notre étude a indiqué que des niveaux plus élevés de résistance à l'insuline et d'autres marqueurs de dysfonctionnement métabolique étaient associés à une diversité amoindrie du microbiome dans les deux cohortes, même après contrôle de l'obésité et d'autres facteurs. Enfin, la troisième partie de la thèse évalue la stabilité et la concordance du microbiome dans les échantillons fécaux prélevés à l'aide de différentes méthodes utilisées dans les programmes de dépistage du cancer colorectal en cours. Nos résultats suggèrent que les collections d'échantillons fécaux couramment utilisées, telles que les tests immunochimiques fécaux et les cartes de prélèvement sur papier, sont en général des supports appropriés pour mesurer la diversité microbiome, bien que des facteurs de stockage, tels que la température ambiante, puissent avoir un impact sur la stabilité de certaines méthodes. En outre, la collecte opportuniste d'échantillons fécaux dans des tubes à tests immunochimiques fécaux après le dépistage du cancer colorectal est probablement une méthode viable pour établir des cohortes avec des échantillons fécaux pré-diagnostics. Dans l'ensemble, cette thèse présente l'état de l'art sur les preuves épidémiologiques du rôle du microbiome dans la tumorigenèse. Elle fournit de nouvelles informations sur l'association des facteurs de risque métaboliques du cancer colorectal avec le microbiome intestinal dans les études populationnelles. Enfin, elle a généré d'importantes données méthodologiques sur l'impact des outils de collecte d'échantillons fécaux sur les mesures microbiennes nécessaires pour les futures recherches épidémiologiques sur le microbiome et le cancer colorectal, ainsi que sur d'autres maladies chroniques
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Investigating the role of the intestinal microbiota in colorectal cancer development : epidemiological approaches
Étude du rôle du microbiote intestinal dans la carcinogenèse colorectale : approches épidémiologiques: Le microbiome intestinal désigne l'ensemble des micro-organismes présents dans le tractus gastro-intestinal. Une symbiose dynamique entre l'hôte et le microbiome existe dans l'intestin et des interactions spécifiques entre le microbiome et le métabolisme de l'hôte, et son système immunitaire, sont essentielles pour façonner la physiologie de l'hôte. L'hypothèse que la perturbation de cette symbiose joue un rôle dans le développement de diverses maladies chroniques, y compris du cancer colorectal, a été émise. En effet, il existe de plus en plus de preuves expérimentales selon lesquelles le microbiome intestinal influence potentiellement le développement de tumeurs par le biais d'une dérégulation du métabolisme de l'hôte et de sa fonction immunitaire. Cependant, les données épidémiologiques reliant le microbiome intestinal à la carcinogenèse colorectale restent limitées car très peu de cohortes existantes ont collecté des échantillons fécaux. Les programmes de dépistage du cancer colorectal, dans lesquels des millions d'échantillons de selles sont prélevés chaque année, pourraient fournir de riches opportunités pour établir des cohortes basées sur la population avec des échantillons répétés et prospectivement collectés. La première partie de la thèse résume de manière systématique la littérature épidémiologique actuelle qui a été publiée au cours de la dernière décennie sur l'association entre le microbiome et le cancer. Nos résultats ont souligné que pour la plupart des indicateurs du microbiome, les preuves étaient encore trop faibles pour tirer des conclusions définitives concernant leur rôle dans le cancer. La deuxième partie de la thèse étudie l'association entre la résistance à l'insuline et l'inflammation - des facteurs de risque reconnus du cancer colorectal - et le microbiome intestinal, dans deux cohortes populationnelles : The Northern Finland Birth Cohort et TwinsUK. Notre étude a indiqué que des niveaux plus élevés de résistance à l'insuline et d'autres marqueurs de dysfonctionnement métabolique étaient associés à une diversité amoindrie du microbiome dans les deux cohortes, même après contrôle de l'obésité et d'autres facteurs. Enfin, la troisième partie de la thèse évalue la stabilité et la concordance du microbiome dans les échantillons fécaux prélevés à l'aide de différentes méthodes utilisées dans les programmes de dépistage du cancer colorectal en cours. Nos résultats suggèrent que les collections d'échantillons fécaux couramment utilisées, telles que les tests immunochimiques fécaux et les cartes de prélèvement sur papier, sont en général des supports appropriés pour mesurer la diversité microbiome, bien que des facteurs de stockage, tels que la température ambiante, puissent avoir un impact sur la stabilité de certaines méthodes. En outre, la collecte opportuniste d'échantillons fécaux dans des tubes à tests immunochimiques fécaux après le dépistage du cancer colorectal est probablement une méthode viable pour établir des cohortes avec des échantillons fécaux pré-diagnostics. Dans l'ensemble, cette thèse présente l'état de l'art sur les preuves épidémiologiques du rôle du microbiome dans la tumorigenèse. Elle fournit de nouvelles informations sur l'association des facteurs de risque métaboliques du cancer colorectal avec le microbiome intestinal dans les études populationnelles. Enfin, elle a généré d'importantes données méthodologiques sur l'impact des outils de collecte d'échantillons fécaux sur les mesures microbiennes nécessaires pour les futures recherches épidémiologiques sur le microbiome et le cancer colorectal, ainsi que sur d'autres maladies chroniques
- 3 February 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (2) , e0180625
Comparison of oral collection methods for 16S rRNA gene and shotgun metagenomic sequencing
To understand how sample collection affects oral microbiome studies, we evaluated the comparability of unpreserved saliva, saliva in glycerol, and mouthwash samples, their room temperature stability, and intraindividual stability over 6 months. Saliva and mouthwash samples were collected from 20 healthy participants 6 months apart. Saliva was divided, with half preserved in glycerol. Some aliquots were frozen immediately, while others were stored at room temperature for a week. DNA was extracted using the PowerSoil Pro and 16S rRNA gene, and shotgun metagenomic sequencing was conducted. Intraclass correlation coefficients (ICCs) from taxonomic and functional tables were compared to assess variability. We estimated sample size requirements based on the intraindividual stability over 6 months. Saliva in glycerol appeared more similar to unpreserved saliva than mouthwash, with higher median ICCs at genus (0.88 vs 0.60), species (0.92 vs 0.64), and gene levels (0.84 vs 0.36; all P < 0.01). Room temperature storage affected saliva in glycerol more than mouthwash (median genus-level ICC = 0.65). No significant differences were observed at the gene level. Intraindividual stability over 6 months was moderate. To detect an odds ratio of 1.5 with one sample per individual, estimated sample sizes ranged from 665 (common species) to 219,547 (rare species). Oral microbiome stability varies by collection method; mouthwash provides greater room temperature stability and may be preferable when immediate freezing is not feasible. For epidemiological studies, consistent use of a single collection method and inclusion of longitudinal sampling can improve reproducibility and power to detect associations with health outcomes. IMPORTANCE: The oral microbiome plays a key role in health and disease, yet methodological inconsistencies in sample collection and processing can introduce variability and limit comparability across studies. This study investigates the impact of different oral sample collection methods on microbiome profiling and their stability over time. We demonstrate that sample type significantly influences taxonomic and functional microbiome profiles, with mouthwash showing greater stability during delayed processing and saliva in glycerol more closely resembling fresh saliva. Importantly, intraindividual microbial communities were only moderately stable over 6 months, emphasizing the need for consistent sampling protocols and consideration of temporal variation. These findings have direct implications for microbiome study design, highlighting that methodological choices can affect reproducibility, statistical power, and biological interpretation. Our results support the use of mouthwash as a practical alternative when freezing is delayed and underscore the value of longitudinal sampling for detecting biologically meaningful changes.
- 3 February 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (2) , e0180625
Comparison of oral collection methods for 16S rRNA gene and shotgun metagenomic sequencing
To understand how sample collection affects oral microbiome studies, we evaluated the comparability of unpreserved saliva, saliva in glycerol, and mouthwash samples, their room temperature stability, and intraindividual stability over 6 months. Saliva and mouthwash samples were collected from 20 healthy participants 6 months apart. Saliva was divided, with half preserved in glycerol. Some aliquots were frozen immediately, while others were stored at room temperature for a week. DNA was extracted using the PowerSoil Pro and 16S rRNA gene, and shotgun metagenomic sequencing was conducted. Intraclass correlation coefficients (ICCs) from taxonomic and functional tables were compared to assess variability. We estimated sample size requirements based on the intraindividual stability over 6 months. Saliva in glycerol appeared more similar to unpreserved saliva than mouthwash, with higher median ICCs at genus (0.88 vs 0.60), species (0.92 vs 0.64), and gene levels (0.84 vs 0.36; all P < 0.01). Room temperature storage affected saliva in glycerol more than mouthwash (median genus-level ICC = 0.65). No significant differences were observed at the gene level. Intraindividual stability over 6 months was moderate. To detect an odds ratio of 1.5 with one sample per individual, estimated sample sizes ranged from 665 (common species) to 219,547 (rare species). Oral microbiome stability varies by collection method; mouthwash provides greater room temperature stability and may be preferable when immediate freezing is not feasible. For epidemiological studies, consistent use of a single collection method and inclusion of longitudinal sampling can improve reproducibility and power to detect associations with health outcomes. IMPORTANCE: The oral microbiome plays a key role in health and disease, yet methodological inconsistencies in sample collection and processing can introduce variability and limit comparability across studies. This study investigates the impact of different oral sample collection methods on microbiome profiling and their stability over time. We demonstrate that sample type significantly influences taxonomic and functional microbiome profiles, with mouthwash showing greater stability during delayed processing and saliva in glycerol more closely resembling fresh saliva. Importantly, intraindividual microbial communities were only moderately stable over 6 months, emphasizing the need for consistent sampling protocols and consideration of temporal variation. These findings have direct implications for microbiome study design, highlighting that methodological choices can affect reproducibility, statistical power, and biological interpretation. Our results support the use of mouthwash as a practical alternative when freezing is delayed and underscore the value of longitudinal sampling for detecting biologically meaningful changes.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundances of the three most dominant phyla, three alpha diversity metrics (observed OTUs, Shannon Diversity, and Faith’s Phylogenetic Diversity) and three beta diversity metrics (Bray-Curtis, unweighted UniFrac, weighted UniFrac), for microbiome stability comparing fecal samples extracted after 4 days at room temperature (baseline), after 4 days at room temperature and stored for a year at -80°C (year 1), and after 4 days at room temperature and stored two years at -80°C (year 2) for five fecal sample collection methods.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundances of the three most dominant phyla, three alpha diversity metrics (observed OTUs, Shannon Diversity, and Faith’s Phylogenetic Diversity) and three beta diversity metrics (Bray-Curtis, unweighted UniFrac, weighted UniFrac), for microbiome stability comparing fecal samples extracted after 4 days at room temperature (baseline), after 4 days at room temperature and stored for a year at -80°C (year 1), and after 4 days at room temperature and stored two years at -80°C (year 2) for five fecal sample collection methods.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 8 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
Differential abundance analysis using the Wilcoxon signed-rank test to identify bacterial taxa at the phylum, family, and genus level which were differentially abundant (FDR < 0.05) among baseline, year 1, and year 2 for each collection method.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 8 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
Differential abundance analysis using the Wilcoxon signed-rank test to identify bacterial taxa at the phylum, family, and genus level which were differentially abundant (FDR < 0.05) among baseline, year 1, and year 2 for each collection method.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundances of the three most dominant phyla, three alpha diversity metrics (observed OTUs, Shannon Diversity, and Faith’s Phylogenetic Diversity) and three beta diversity metrics (Bray-Curtis, unweighted UniFrac, weighted UniFrac),for microbiome stability comparing oral samples extracted after 4 days at room temperature (baseline), after 4 days at room temperature and stored for a year at -80°C (year 1), and after 4 days at room temperature and stored two years at -80°C (year 2) for two oral sample collection methods.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundances of the three most dominant phyla, three alpha diversity metrics (observed OTUs, Shannon Diversity, and Faith’s Phylogenetic Diversity) and three beta diversity metrics (Bray-Curtis, unweighted UniFrac, weighted UniFrac),for microbiome stability comparing oral samples extracted after 4 days at room temperature (baseline), after 4 days at room temperature and stored for a year at -80°C (year 1), and after 4 days at room temperature and stored two years at -80°C (year 2) for two oral sample collection methods.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on random effects models for microbiome stability comparing oral samples extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for two oral sample collection methods.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on random effects models for microbiome stability comparing oral samples extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for two oral sample collection methods.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundance of the top 20 genus for microbiome stability comparing fecal samples extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for five fecal sample collection methods.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundance of the top 20 genus for microbiome stability comparing fecal samples extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for five fecal sample collection methods.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundance of the top 20 genus for microbiome stability comparing oral samples extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for two oral sample collection methods.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundance of the top 20 genus for microbiome stability comparing oral samples extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for two oral sample collection methods.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundances of the three most dominant phyla, three alpha diversity metrics (observed OTUs, Shannon Diversity, and Faith’s Phylogenetic Diversity) and three beta diversity metrics (Bray-Curtis, unweighted UniFrac, weighted UniFrac),for microbiome stability for duplicated or triplicated fecal samples – discarded from the main analysis - extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for five fecal sample collection methods.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Stability of the Fecal and Oral Microbiome over 2 Years at −80°C for Multiple Collection Methods
ICCs based on the relative abundances of the three most dominant phyla, three alpha diversity metrics (observed OTUs, Shannon Diversity, and Faith’s Phylogenetic Diversity) and three beta diversity metrics (Bray-Curtis, unweighted UniFrac, weighted UniFrac),for microbiome stability for duplicated or triplicated fecal samples – discarded from the main analysis - extracted upon receipt (baseline), after a year stored at -80°C (year 1), and after two years stored at -80°C (year 2) for five fecal sample collection methods.